We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Equity Residential
EQR
$24.9B
| $5.83M | 0.13% |
74,349
-6,014
| -7% | -$470K |
|
177
Sempra
SRE
$57.9B
| $5.83M | 0.13% |
106,242
-5,908
| -5% | -$326K |
|
178
Intuit
INTU
$86.5B
| $5.82M | 0.13% |
60,009
-2,764
| -4% | -$257K |
|
179
PG&E
PCG
$38.3B
| $5.79M | 0.13% |
108,171
-4,891
| -4% | -$270K |
|
180
BioMarin Pharmaceuticals
BMRN
$11.6B
| $5.77M | 0.13% |
46,316
| – | – |
|
181
Aon
AON
$76.5B
| $5.77M | 0.13% |
59,999
-5,079
| -8% | -$491K |
|
|
TWTR
182
DELISTED
Twitter, Inc.
TWTR
| $5.75M | 0.13% |
114,714
-460
| -0.4% | -$20.4K |
|
183
Cencora
COR
$60.6B
| $5.73M | 0.13% |
50,386
-4,330
| -8% | -$436K |
|
|
DFS
184
DELISTED
Discover Financial Services
DFS
| $5.69M | 0.13% |
101,022
-8,537
| -8% | -$505K |
|
|
VIAB
185
DELISTED
Viacom Inc. Class B
VIAB
| $5.56M | 0.13% |
81,396
-6,203
| -7% | -$428K |
|
|
SE
186
DELISTED
Spectra Energy Corp Wi
SE
| $5.5M | 0.13% |
152,091
-9,766
| -6% | -$342K |
|
|
PXD
187
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.45M | 0.13% |
33,337
-1,330
| -4% | -$204K |
|
188
Ventas
VTR
$48B
| $5.36M | 0.12% |
64,231
+2,546
| +4% | +$219K |
|
189
Devon Energy
DVN
$52.1B
| $5.33M | 0.12% |
88,405
-5,322
| -6% | -$325K |
|
|
LO
190
DELISTED
LORILLARD INC COM STK
LO
| $5.33M | 0.12% |
81,598
-4,989
| -6% | -$332K |
|
|
CB
191
DELISTED
CHUBB CORPORATION
CB
| $5.33M | 0.12% |
52,742
-4,462
| -8% | -$452K |
|
192
Bath & Body Works
BBWI
$4.06B
| $5.32M | 0.12% |
69,782
-3,836
| -5% | -$277K |
|
193
Netflix
NFLX
$299B
| $5.31M | 0.12% |
892,430
-37,030
| -4% | -$225K |
|
|
BRCM
194
DELISTED
BROADCOM CORP CL-A
BRCM
| $5.3M | 0.12% |
122,421
-7,542
| -6% | -$329K |
|
195
Aptiv
APTV
$12B
| $5.29M | 0.12% |
66,353
-4,644
| -7% | -$349K |
|
196
Perrigo
PRGO
$1.4B
| $5.29M | 0.12% |
31,963
+357
| +1% | +$56.9K |
|
197
Boston Scientific
BSX
$69.5B
| $5.28M | 0.12% |
297,547
-26,724
| -8% | -$422K |
|
198
Cummins
CMI
$87.5B
| $5.28M | 0.12% |
38,077
-3,604
| -9% | -$508K |
|
199
Zoetis
ZTS
$32.4B
| $5.25M | 0.12% |
113,499
-5,875
| -5% | -$265K |
|
200
Ameriprise Financial
AMP
$48.3B
| $5.2M | 0.12% |
39,721
-4,588
| -10% | -$604K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.